Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Sean M. Mitchell

26 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Safety 13 Depression 8 Addiction 6 Clinical Trial 6 Mechanism of Action 5 Observational Study 5 Brain Imaging 4 Healthy Volunteers 4 Wellbeing 3 Animal Study 3 Receptor Pharmacology 3 PTSD 3

Journals

PsyArXiv 4 Journal of psychoactive drugs 3 ClinicalTrials.gov 1 BMC Medicine 1 Human Brain Mapping 1 JoCN Forum 1 Psychoactives 1 Philosophical Psychology 1

Publication history

A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-09-09 The need for another tool: Australian healthcare professionals on the use of psilocybin for existential distress in people with cancerBMC Medicine · 2026-07-06 Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic CircuitsHuman Brain Mapping · 2026-07-01 Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyJoCN Forum · 2026-05-08 Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-13 Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-10 Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia's clinical landscape.The Australian and New Zealand journal of psychiatry · 2026-02-01 From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.Translational behavioral medicine · 2026-01-07 Comparative Efficacy of Psilocybin and MDMA in PTSD Treatment: A Systematic Review of Long-Term OutcomesBerkeley Scientific Journal · 2025-11-12 Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.Journal of psychoactive drugs · 2025-11-10 551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHESThe International Journal of Neuropsychopharmacology · 2025-07-31 Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study.Journal of psychoactive drugs · 2025-03-05 Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuitsbioRxiv · 2024-11-07 Psilocybin-assisted therapy and HIV-related shame.Scientific reports · 2024-08-02 Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reportsJournal of Psychedelic Studies · 2024-07-17 Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectanciesPsyArXiv · 2024-06-10 Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectanciesPsyArXiv · 2024-06-10 Do undergraduates’ views of psychedelics relate to the context for psychedelic use?PsyArXiv · 2024-04-24 Do undergraduates’ views of psychedelics relate to the context for psychedelic use?PsyArXiv · 2024-04-24 Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.Journal of psychoactive drugs · 2024-01-01 A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapymedRxiv · 2023-04-19 Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.The International journal on drug policy · 2022-10-01 Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.PloS one · 2022-01-01 Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine.The Journal of neuroscience: the official journal of the Society for Neuroscience · 2021-02-03 Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.EClinicalMedicine · 2020-10-01 T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30

Author directory